Target intelligence / Profile preview

RNA, U6 small nuclear 513, pseudogene (RNU6-513P)

Target: RNU6-513P
Molecular classification: Other — Pseudogene, Non-coding RNA

Overview

RNA, U6 small nuclear 513, pseudogene (RNU6-513P) is a non-functional, non-coding genetic element in the human genome that resembles the U6 small nuclear RNA gene. U6 snRNA is a highly conserved small nuclear RNA essential for the activity of the spliceosome, the complex responsible for removing introns from precursor mRNA in eukaryotic cells[1][3][5]. RNU6-513P, however, is a pseudogene version created by retrotransposition or other genomic mechanisms and does not encode a functional RNA or participate in the splicing reaction. While some pseudogenes are transcribed and may produce small RNAs with potential regulatory or epigenetic effects (such as RNA interference or miRNA sponging), there is currently no evidence for direct biological function or disease involvement for RNU6-513P[2][5]. It is cataloged for completeness in genomic annotation but is not considered a protein-coding gene or therapeutic target[4].

Other names: RNU6-513PRNA, U6 small nuclear 513, pseudogene

Mechanism of action

None. No drugs target this molecule or pseudogene directly.

Biological functions

None directly for RNU6-513P. In general, pseudogenes do not encode functional products; however, some pseudogene-derived RNAs may have possible regulatory roles (e.g., acting as microRNA decoys or producing small interfering RNAs), but these functions are not established for RNU6-513P specifically.

Disease associations

None established. Although some pseudogenes can participate in regulatory networks or disease processes (e.g., via small RNA production or as competing endogenous RNAs), there is no direct evidence for disease associations specific to RNU6-513P.

Safety considerations

None known. As a pseudogene, RNU6-513P is not a target for therapeutic intervention, so safety/therapeutic concerns do not apply.

Beyond the preview

Go deeper on RNA, U6 small nuclear 513, pseudogene (RNU6-513P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 513, pseudogene (RNU6-513P).

Explore the full profile